Assessment of retinal arteriolar tortuosity in patients with COL4A1 or COL4A2 mutations.


Journal

Retina (Philadelphia, Pa.)
ISSN: 1539-2864
Titre abrégé: Retina
Pays: United States
ID NLM: 8309919

Informations de publication

Date de publication:
09 Oct 2024
Historique:
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 15 10 2024
Statut: aheadofprint

Résumé

Qualitative and quantitative analyzes of retinal arteriolar tortuosity (RAT) in patients with COL4A1 and COL4A2 mutations to identify a tortuosity index (TI) threshold for detecting increased RAT. Fifty-two eyes of 28 patients were included. Group 1 included eyes with a normal arteriolar pattern (n=19, 37%), group 2 included eyes with moderately increased arteriolar tortuosity (n=13, 25%), and group 3 included eyes with typical abnormal arteriolar tortuosity (n=20, 38%). The TI was measured by calculating the arc-to-chord ratio of arterioles and venules in the posterior pole. The mean arteriolar TI was significantly higher in all groups with a COL4A1/A2 mutation compared to controls: 1.19 ± 0.03, 1.24 ±0.05, and 1.57 ± 0.23 in groups 1, 2 and 3, respectively, vs. 1.12 ± 0.01 (all p <0.0001). The TI threshold was 1.13, with a sensitivity of 98.1% and a specificity of 100%. The area under the curve was 0.995. Measuring the arteriolar TI allowed diagnosing increased RAT in all eyes with a COL4A1/A2 mutation, whereas the subjective assessment suspected or detected it in only 62% of eyes. In adult patients with cerebral microangiopathy, detecting increased RAT, even when mild, directs the diagnosis towards COL4A1/A2-related cerebroretinal angiopathy.

Identifiants

pubmed: 39405554
doi: 10.1097/IAE.0000000000004290
pii: 00006982-990000000-00821
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Valérie Krivosic (V)

Ophthalmology Department, Hôpital Lariboisière, APHP and Université Paris-Cité, France.
Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Oeil (CERVCO), Hôpital Lariboisière, Paris, AP-HP, France.

Paul Goupillou (P)

Ophthalmology Department, Hôpital Lariboisière, APHP and Université Paris-Cité, France.

Frederic Buffon-Porcher (F)

Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Oeil (CERVCO), Hôpital Lariboisière, Paris, AP-HP, France.
Translational Neurovascular Centre and Departement of Neurology, FHU NeuroVasc, Paris, France.

Hélène Morel (H)

Université Paris-Cité, INSERM NeuroDiderot UMR 1141; AP-HP, Paris, France.

Stéphanie Guey (S)

Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Oeil (CERVCO), Hôpital Lariboisière, Paris, AP-HP, France.
Translational Neurovascular Centre and Departement of Neurology, FHU NeuroVasc, Paris, France.
Université Paris-Cité, Inserm, NeuroDiderot, U1161, F-75019 Paris, France.

Ramin Tadayoni (R)

Ophthalmology Department, Hôpital Lariboisière, APHP and Université Paris-Cité, France.
Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Oeil (CERVCO), Hôpital Lariboisière, Paris, AP-HP, France.

Elisabeth Tournier Lasserve (ET)

Université Paris-Cité, INSERM NeuroDiderot UMR 1141; AP-HP, Paris, France.

Hugues Chabriat (H)

Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Oeil (CERVCO), Hôpital Lariboisière, Paris, AP-HP, France.
Translational Neurovascular Centre and Departement of Neurology, FHU NeuroVasc, Paris, France.
Université Paris-Cité, Inserm, NeuroDiderot, U1161, F-75019 Paris, France.

Alain Gaudric (A)

Ophthalmology Department, Hôpital Lariboisière, APHP and Université Paris-Cité, France.
Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Oeil (CERVCO), Hôpital Lariboisière, Paris, AP-HP, France.

Classifications MeSH